• 제목/요약/키워드: tumor imaging

검색결과 1,256건 처리시간 0.031초

수술 전 선행보조치료를 받은 직장암 환자의 직장 자기공명영상의 해석 (Interpretation of Rectal MRI after Neoadjuvant Treatment in Patients with Rectal Cancer)

  • 서니은;임준석
    • 대한영상의학회지
    • /
    • 제84권3호
    • /
    • pp.550-564
    • /
    • 2023
  • 자기공명영상은 현재 선행보조치료 후 직장암을 평가할 수 있는 가장 우수한 영상검사이다. 선행보조치료 후 시행하는 직장 자기공명영상의 목적은 직장암의 절제가능성을 평가하고 임상적으로 완전관해로 생각되는 환자들에서 장기 보존 전략을 적용할 수 있게 하는 것이다. 이번 종설에서는 선행보조치료 후 자기공명영상에서 평가해야 할 중요한 소견들을 체계적으로 평가하는 방법을 다루고자 한다. 먼저 원발 종양의 치료 반응을 평가하고, 완전관해를 시사하는 영상 소견에 대해 고찰하고자 한다. 또한 선행보조치료 후 원발 종양과 주변 구조물과의 관계, 임파절, extramural venous invasion, tumor deposit의 소견을 다루고자 한다. 이러한 영상 소견 및 임상적 중요성에 대한 지식은 정확하고 임상적으로 의미 있는 판독을 제공하는데 기여할 것이다.

4차원 영상기법 Time Resolved Imaging of Contrast Kinetics MRA의 유용성 (Four Dimension(4D) Time Resolved Imaging of Contrast Kinetics(TRICKS) MR Angiography)

  • 임청환;배성진
    • 한국콘텐츠학회:학술대회논문집
    • /
    • 한국콘텐츠학회 2009년도 춘계 종합학술대회 논문집
    • /
    • pp.1105-1110
    • /
    • 2009
  • Time Resolved Imaging of Contrast Kinetics 기법을 이용한 4차원 자기공명혈관조영술(TRICKS -MRA)영상과 기존 TOF-MRA영상을 비교하여 임상적 유용성에 대해 알아보고자 하였다. 총 17명 중 뇌 혈관 질환이 의심되는 11명과 뇌 종양을 의심하는 6명을 대상으로 TOF-MRA와 TRICKS -MRA을 시행한 후 17대상자 중 11명에서 DSA를 추가적으로 시행하였다. TOF-MRA는 공간해상력보다 시간해상력이 부족하였고, TRICKS-MRA에서는 TOF-MRA보다 공간분해능은 부족한 점이 많지만 영상판독에 큰 영향은 없었고 모든 대상자에서 동맥과 정맥의 구별이 가능하여 시간분해능이 우수 한 것을 나타났다. 또한 종양과 혈관과의 관계성 평가에서 TOF-MRA보다 좋은 것으로 나타났다. TRICKS-MRA방법은 시간대별로 동맥, 모세혈관, 정맥기를 신속하면서 쉽게 4차원적으로 영상화가 가능하여 앞으로 임상에서 이용도가 더욱 증가 할 것으로 사료된다.

  • PDF

Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology

  • Dong Ho Lee;Bohyun Kim;Eun Sun Lee;Hyoung Jung Kim;Ji Hye Min;Jeong Min Lee;Moon Hyung Choi;Nieun Seo;Sang Hyun Choi;Seong Hyun Kim;Seung Soo Lee;Yang Shin Park;Yong Eun Chung;The Korean Society of Abdominal Radiology
    • Korean Journal of Radiology
    • /
    • 제22권1호
    • /
    • pp.41-62
    • /
    • 2021
  • Radiologic imaging is important for evaluating extrahepatic bile duct (EHD) cancers; it is used for staging tumors and evaluating the suitability of surgical resection, as surgery may be contraindicated in some cases regardless of tumor stage. However, the published general recommendations for EHD cancer and recommendations guided by the perspectives of radiologists are limited. The Korean Society of Abdominal Radiology (KSAR) study group for EHD cancer developed key questions and corresponding recommendations for the radiologic evaluation of EHD cancer and organized them into 4 sections: nomenclature and definition, imaging technique, cancer evaluation, and tumor response. A structured reporting form was also developed to allow the progressive accumulation of standardized data, which will facilitate multicenter studies and contribute more evidence for the development of recommendations.

Perfusion MR Imaging in Gliomas: Comparison with Histologic Tumor Grade

  • Sun Joo Lee;Jae Hyoung Kim;Young Mee Kim;Gyung Kyu Lee;Eun Ja Lee;In Sung Park;Jin-Myung Jung;Kyeong Hun Kang;Taemin Shin
    • Korean Journal of Radiology
    • /
    • 제2권1호
    • /
    • pp.1-7
    • /
    • 2001
  • Objective: To determine the usefulness of perfusion MR imaging in assessing the histologic grade of cerebral gliomas. Materials and Methods: In order to determine relative cerebral blood volume (rCBV), 22 patients with pathologically proven gliomas (9 glioblastomas, 9 anaplastic gliomas and 4 low-grade gliomas) underwent dynamic contrast-enhanced T2*-weighted and conventional T1- and T2-weighted imaging. rCBV maps were obtained by fitting a gamma-variate function to the contrast material concentration versus time curve. rCBV ratios between tumor and normal white matter (maximum rCBV of tumor / rCBV of contralateral white matter) were calculated and compared between glioblastomas, anaplastic gliomas and low-grade gliomas. Results: Mean rCBV ratios were 4.90°±1.01 for glioblastomas, 3.97°±0.56 for anaplastic gliomas and 1.75°±1.51 for low-grade gliomas, and were thus significantly different; p < .05 between glioblastomas and anaplastic gliomas, p < .05 between anaplastic gliomas and low-grade gliomas, p < .01 between glioblastomas and low-grade gliomas. The rCBV ratio cutoff value which permitted discrimination between high-grade (glioblastomas and anaplastic gliomas) and low-grade gliomas was 2.60, and the sensitivity and specificity of this value were 100% and 75%, respectively. Conclusion: Perfusion MR imaging is a useful and reliable technique for estimating the histologic grade of gliomas.

  • PDF

재발 난소암의 진단에서의 $^{18}F$-fluorodeoxyglucose PET/CT의 유용성: Enhanced CT와 Tumor Marker CA 125와의 비교 (Role of $^{18}F$-fluorodeoxyglucose PET/CT in Recurrent Ovary Cancer)

  • 오주현;유이령;최우희;이원형;김성훈;정수교
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권3호
    • /
    • pp.209-217
    • /
    • 2008
  • 목적: 현재까지 난소암의 재발을 평가하는데 해부학적 영상 검사와 tumor marker들이 주를 이루고 있다. 저자들은 재발 난소암의 진단에서 CT, 그리고 tumor marker CA 125와 비교하여 $^{18}F$-FDG PET/CT의 유용성을 알아보고자 하였다. 대상 및 방법: 조직학적으로 확진 된 난소암 환자 중 재발 평가를 위하여 PET/CT를 시행하고 한달 이내로 pelvis CT 검사를 시행한 환자 73명을 대상으로 하였다. Tumor marker CA 125은 모두에서 측정하였다. PET/CT 영상에서 의심되는 부위의 maximum SUV를 기록하였다. 26명은 수술 또는 생검을 통해 확진되었고, 나머지 47명은 임상 소견과 추적 영상 검사를 통하여 진단하였다. 결과: 난소암의 재발을 진단하는데 PET/CT의 예민도는 93%였고, 특이도는 88%였다. Enhanced CT의 예민도는 83%, 특이도는 88%였다. Tumor marker CA 125의 예민도와 특이도는 각각 50%와 95%였다. 결론: 재발 난소암의 진단에서 FDG PET/CT의 예민도가 CT보다 좋았으나 통계학적으로 의미 있는 차이는 아니였고, 특이도는 PET/CT 와 CT가 비슷하였다. Tumor marker CA 125보다는 PET/CT의 예민도가 월등히 높았다. 하지만 재발 환자에서 위의 세 검사의 일치도는 43%로 낮은 편으로, 난소암 환자의 경과 관찰 중, 특히 PET/CT 영상에서, 양성 소견이 보이면 재발의 가능성이 높다.

Thallium-201 SPECT 뇌종양 영상 (Thallium-201 SPECT Imaging of Brain Tumors)

  • 김상은;최창운;이동수;정준기;이명철;고창순;윤병우;노재규;정희원
    • 대한핵의학회지
    • /
    • 제26권1호
    • /
    • pp.14-25
    • /
    • 1992
  • Thallium-201 $(^{201}T1)$ SPECT studies were performed on a normal volunteer and 12 patients with intracerebral lesions: 3 patients with gliomas, 3 patients with meningiomas, 1 patient each with metastatic tumor, brain abscess, and cerebral infarction, and 3 postirradiation patients. (2 with metastatic tumors, 1 with lymphoma). A $^{201}T1$ index, based on the ratio of $^{201}T1$ uptake in the brain lesion versus the homologous contralateral brain, was calculated and compared with tumor histology and CT/MRI findings. The SPECT $^{201}T1$ scan showed minimal uptake of tracer in a normal brain. There was substantial uptake of $^{201}T1$ in high-grade gliomas (index>1.5) with little uptake in low-grade lesions. A previously irradiated patient with recurrent astrocytoma, in whom MRI study was unable to distinguish tumor recurrence from necrosis, showed the lesions with high $^{201}T1$ indices in both hemispheric regions (2.50/1.93), suggesting tumor recurrence. Two meningiomas and a metastatic tumor showed varying degrees of $^{201}T1$ uptake (index $1.71\sim8.15$), revealing that $^{201}T1$ uptake is not exclusive to high-grade gliomas. In 2 postirradiation patients with metastatic tumors, no abnormal $^{201}T1$ uptake was found in the cerebral lesions, shortly after the initiation of radiation therapy or despite the persistence of enhancing lesions-though improved-on MR images, suggesting that $^{201}T1$ uptake may reflect the metabolic and possibly clonogenic activities of tumors and the brain $^{201}T1$ SPECT imaging might be valuable for the evaluation of tumor responsiveness to the therapy and for early detection of tumor recurrence. A patient with brain abscess on antibiotic treatment, showig increased uptake of $^{201}T1$ in the resolving lesions (index 2.87/1.52) is discussed. In a patient with cerebral infarction, there was no abnormal uptake of $^{201}T1$ in infarcted tissue. When using a threshold index of 1.5, correlation rate between $^{201}T1$ uptake and contrast enhancement of the cerebral lesions on CT/MRI was 73% (8/11). In conclusion, the brain $^{201}T1$ SPECT imaging may be useful for assessment of tumor response to the therapy and to predict low-or high-grade lesions.

  • PDF

Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients

  • Dong Ik Cha;Kyung Mi Jang;Seong Hyun Kim;Young Kon Kim;Honsoul Kim;Soo Hyun Ahn
    • Korean Journal of Radiology
    • /
    • 제21권4호
    • /
    • pp.402-412
    • /
    • 2020
  • Objective: To evaluate the performance of predicting early recurrence using preoperative factors only in comparison with using both pre-/postoperative factors. Materials and Methods: We retrospectively reviewed 549 patients who had undergone curative resection for single hepatcellular carcinoma (HCC) within Milan criteria. Multivariable analysis was performed to identify pre-/postoperative high-risk factors of early recurrence after hepatic resection for HCC. Two prediction models for early HCC recurrence determined by stepwise variable selection methods based on Akaike information criterion were built, either based on preoperative factors alone or both pre-/postoperative factors. Area under the curve (AUC) for each receiver operating characteristic curve of the two models was calculated, and the two curves were compared for non-inferiority testing. The predictive models of early HCC recurrence were internally validated by bootstrap resampling method. Results: Multivariable analysis on preoperative factors alone identified aspartate aminotransferase/platelet ratio index (OR, 1.632; 95% CI, 1.056-2.522; p = 0.027), tumor size (OR, 1.025; 95% CI, 0.002-1.049; p = 0.031), arterial rim enhancement of the tumor (OR, 2.350; 95% CI, 1.297-4.260; p = 0.005), and presence of nonhypervascular hepatobiliary hypointense nodules (OR, 1.983; 95% CI, 1.049-3.750; p = 0.035) on gadoxetic acid-enhanced magnetic resonance imaging as significant factors. After adding postoperative histopathologic factors, presence of microvascular invasion (OR, 1.868; 95% CI, 1.155-3.022; p = 0.011) became an additional significant factor, while tumor size became insignificant (p = 0.119). Comparison of the AUCs of the two models showed that the prediction model built on preoperative factors alone was not inferior to that including both pre-/postoperative factors {AUC for preoperative factors only, 0.673 (95% confidence interval [CI], 0.623-0.723) vs. AUC after adding postoperative factors, 0.691 (95% CI, 0.639-0.744); p = 0.0013}. Bootstrap resampling method showed that both the models were valid. Conclusion: Risk stratification solely based on preoperative imaging and laboratory factors was not inferior to that based on postoperative histopathologic risk factors in predicting early recurrence after curative resection in within Milan criteria single HCC patients.

Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

  • Chan Park;Jin Hyoung Kim;Pyeong Hwa Kim;So Yeon Kim;Dong Il Gwon;Hee Ho Chu;Minho Park;Joonho Hur;Jin Young Kim;Dong Joon Kim
    • Korean Journal of Radiology
    • /
    • 제22권2호
    • /
    • pp.213-224
    • /
    • 2021
  • Objective: Clinical outcomes of patients who undergo transarterial chemoembolization (TACE) for single small hepatocellular carcinoma (HCC) are not consistent, and may differ based on certain imaging findings. This retrospective study was aimed at determining the efficacy of pre-TACE CT or MR imaging findings in predicting survival outcomes in patients with small HCC upon being treated with TACE. Besides, the study proposed to build a risk prediction model for these patients. Materials and Methods: Altogether, 750 patients with functionally good hepatic reserve who received TACE as the first-line treatment for single small HCC between 2004 and 2014 were included in the study. These patients were randomly assigned into training (n = 525) and validation (n = 225) sets. Results: According to the results of a multivariable Cox analysis, three pre-TACE imaging findings (tumor margin, tumor location, enhancement pattern) and two clinical factors (age, serum albumin level) were selected and scored to create predictive models for overall, local tumor progression (LTP)-free, and progression-free survival in the training set. The median overall survival time in the validation set were 137.5 months, 76.1 months, and 44.0 months for low-, intermediate-, and high-risk groups, respectively (p < 0.001). Time-dependent receiver operating characteristic curves of the predictive models for overall, LTP-free, and progression-free survival applied to the validation cohort showed acceptable areas under the curve values (0.734, 0.802, and 0.775 for overall survival; 0.738, 0.789, and 0.791 for LTP-free survival; and 0.671, 0.733, and 0.694 for progression-free survival at 3, 5, and 10 years, respectively). Conclusion: Pre-TACE CT or MR imaging findings could predict survival outcomes in patients with small HCC upon treatment with TACE. Our predictive models including three imaging predictors could be helpful in prognostication, identification, and selection of suitable candidates for TACE in patients with single small HCC.